The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

660 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-20

Study Completion Date

2021-01-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A study based on a chart review of participants that presented with a sudden blood clot in the lung

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism

NCT05318092

Pulmonary Embolism Acute Pulmonary Embolism

COMPLETED NA

US Pivotal Clinical Study of the Adient Absorbable Filter for the Prevention of Pulmonary Embolism

NCT05127915

Pulmonary Embolism

ACTIVE_NOT_RECRUITING NA

Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism

NCT02396758

Pulmonary Embolism and Thrombosis

COMPLETED PHASE4

Short-term Clinical Deterioration After Acute Pulmonary Embolism

NCT03915925

Pulmonary Embolism

COMPLETED

Study on the Clinical Course Of Pulmonary Embolism

NCT01781858

Cardiovascular Diseases Venous Thromboembolism Pulmonary Hypertension

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Embolism (PE) Pulmonary Thromboembolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adult with acute PE before the introduction of apixaban

Non-Interventional

Intervention Type OTHER

Non-Interventional

Adult with acute PE after the introduction of apixaban

Non-Interventional

Intervention Type OTHER

Non-Interventional

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-Interventional

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults participants at date of admission
* Primary presentation consistent with PE followed by objectively-confirmed acute PE
* Received anti-coagulation upon diagnosis of PE during study period and in receipt of anti-coagulation at discharge

Exclusion Criteria

* PE diagnosed during a hospital admission for a reason other than PE during the study period
* Patients receiving anticoagulation at the time of presentation
* Patients presenting outside the defined study period

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No